Profile data is unavailable for this security.
About the company
Bioalpha Holdings Berhad is a Malaysia-based integrated health supplement company. It is principally involved in agricultural development, research and development (R&D), manufacturing, distribution and marketing of functional food and health supplement products under Original Design Manufacturer (ODM) and Original Brand Manufacturer (OBM) basis, as well as operating a retail pharmacy chain under the brand, Constant. Its product categories include Health Food, Health Drinks, Tea Ranges, Health supplements, Beauty@NuShine, and Herbal Farming. The Company's health supplement products comprise processed herbs, formulated ingredients, functional foods as well as herbal and non-herbal supplements that offer a variety of health benefits, including general health maintenance, improving blood circulation, enhancing vitality and general well-being. All of its health supplement products are halal-certified and are sold in Malaysia with Indonesia and China as export markets.
- Revenue in MYR (TTM)46.08m
- Net income in MYR-38.55m
- Incorporated2011
- Employees--
- LocationBioalpha Holdings BhdNo. 10, Jalan P/9A, Seksyen 13BANDAR BARU BANGI 43650MalaysiaMYS
- Phone+60 389222286
- Fax+60 389222287
- Websitehttp://bioa.com.my/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shenzhen Neptunus Intrlng Bi tchnq CoLtd | 693.11m | 15.70m | 146.65m | 1.44k | 9.34 | 0.2481 | 4.68 | 0.2116 | 0.0155 | 0.0155 | 0.6853 | 0.5845 | 0.7437 | 3.03 | 6.51 | 796,388.60 | 1.01 | 3.46 | 1.57 | 5.13 | 41.81 | 49.14 | 1.36 | 4.29 | 1.95 | -- | 0.0811 | 0.00 | 7.92 | 4.19 | -55.60 | -12.89 | -11.10 | -- |
Bioalpha Holdings Bhd | 46.08m | -38.55m | 147.68m | -- | -- | 1.12 | -- | 3.20 | -0.0275 | -0.0275 | 0.0338 | 0.0934 | 0.248 | 6.20 | 5.52 | -- | -21.57 | -12.76 | -24.65 | -13.77 | -0.5013 | 7.95 | -86.99 | -44.60 | 1.26 | -31.34 | 0.0949 | -- | 28.74 | -8.04 | 19.41 | -- | -39.39 | -- |
Inoviq Ltd | 2.37m | -20.51m | 150.76m | 85.00 | -- | 2.86 | -- | 63.67 | -0.0708 | -0.0708 | 0.0082 | 0.182 | 0.0339 | 2.10 | 0.873 | -- | -29.33 | -47.68 | -32.18 | -50.76 | 95.07 | -- | -866.27 | -2,527.82 | 4.93 | -- | 0.0332 | -- | 119.59 | 153.31 | 50.71 | -- | -- | -- |
DOD Biotech PCL | 87.89m | 2.62m | 151.77m | 425.00 | 65.43 | 1.11 | 12.42 | 1.73 | 0.0397 | 0.0105 | 1.51 | 2.35 | 0.4935 | 3.34 | 9.00 | -- | 1.52 | 3.55 | 1.95 | 4.49 | 38.77 | 41.70 | 3.07 | 6.66 | 0.7834 | 7.10 | 0.1351 | -- | 26.25 | 0.3514 | 105.89 | -41.91 | -13.87 | -- |
Cynata Therapeutics Ltd | 1.37m | -42.99m | 152.81m | 0.00 | -- | 3.95 | -- | 111.18 | -0.0873 | -0.0873 | 0.0027 | 0.0683 | 0.0257 | -- | 4.26 | -- | -80.33 | -38.07 | -87.15 | -41.10 | -- | -- | -3,127.93 | -513.73 | -- | -- | 0.00 | -- | -94.96 | 19.81 | -162.20 | -- | -- | -- |